Moteur de recherche d’entreprises européennes
Financement britannique (7 073 464 £) : LSI DTCs 2007 - Académie supérieure d’ingénierie tissulaire et de médecine régénérative Ukri 01/10/2008 Recherche et innovation du Royaume-Uni, Royaume Uni
Vue d’ensemble
Texte
LSI DTCs 2007 - Académie supérieure d’ingénierie tissulaire et de médecine régénérative
| Abstract | Definition: A rapidly developing area at the interfaces of engineering/physical sciences, life sciences and medicine. Includes:- cell therapies (including stem cells), three dimensional cell/ matrix constructs, bioactive scaffolds, regenerative devices, in vitro tissue models for drug discovery and pre-clinical research.Social and economic needs include:Increased longevity of the ageing population with expectations of an active lifestyle and government requirements for a longer working life.Need to reduce healthcare costs, shorten hospital stays and achieve more rapid rehabilitationAn emergent disruptive industrial sector at the interface between pharmaceutical and medical devicesRequirement for relevant laboratory biological systems for screening and selection of drugs at theearly development stage, coupled with Reduction, Refinement, Replacement of in vivo testing. Translational barriers and industry needs: The tissue engineering/ regenerative medicine industry needs an increase in the number of trained multidisciplinary personnel to translate basic research, deliver new product developments, enhance manufacturing and processing capacity, to develop preclinical test methodologies and to develop standards and work within a dynamic regulatory environment. Evidence from N8 industry workshop on regenerative medicine.Academic needs: A rapidly emerging internationally competitive interdisciplinary area requiring new blood --------------------- |
| Category | Training Grant |
| Reference | EP/F500513/1 |
| Status | Closed |
| Funded period start | 01/10/2008 |
| Funded period end | 30/09/2018 |
| Funded value | £7 073 464,00 |
| Source | https://gtr.ukri.org/projects?ref=EP%2FF500513%2F1 |
Participating Organisations
| University of Leeds | |
| Intercytex Ltd | |
| Innovate UK | |
| Axordia Ltd | |
| Yorkshire Forward | |
| Xiros Plc | |
| Gluco Ltd (Leeds Innovation Centre) | |
| Tissue Science Laboratories (Uk) Ltd | |
| DePuy Synthes (International) | |
| National Blood Service | |
| BITECIC Ltd | |
| White Rose University Consortium | |
| CellTran Ltd | |
| Smith and Nephew Medical Ltd |
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : University of Leeds, LS2 9JT Leeds, Royaume Uni.